PARLIAMENTARY WRITTEN QUESTION
(1 July 2025)
Question Asked
Asked by:
Katie White (Labour)
Answer
Insulin pumps were recommended for certain groups of the type 1 diabetes population in 2008 via the National Institute for Health and Care Excellence’s (NICE) Technology Appraisal TA151.
The National Health Service is legally obliged to fund and resource medicines and other treatments recommended by NICE’s Technology Appraisals, and commissioners are required to meet the costs. Local integrated care board leaders should already have plans in place, and budgets identified, to meet the needs of their populations who meet the recommended eligibility criteria of TA151, in accordance with the NHS Constitution.
A national contribution is available to meet 75% of the additional costs of the requirements of NICE TA943 on hybrid closed loop (HCL) systems, as a funding variation was agreed with NICE. Insulin pumps are one of the components of HCL systems.
Answered by:
()
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.